Rapid Micro Biosystems Inc
NASDAQ:RPID
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vizio Holding Corp
NYSE:VZIO
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (0.5), the stock would be worth $-0.57 (126% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1.8 | $2.19 |
0%
|
| 3-Year Average | 0.5 | $-0.57 |
-126%
|
| Industry Average | 23.5 | $-27.85 |
-1 372%
|
| Country Average | 14.4 | $-17.01 |
-877%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Rapid Micro Biosystems Inc
NASDAQ:RPID
|
97.6m USD | -1.8 | -2.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 1 225.9 | 4 278.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
197.4B USD | 20.3 | 29.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
137.5B USD | 19.3 | 38.1 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 30.1 | 46.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.1B CHF | 17.1 | -126 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
294B CNY | 16 | 15.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.5B USD | 19.6 | 26.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
32.9B USD | 33 | 51.2 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.8B USD | 12.1 | 22 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27B USD | 22.9 | 31 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
Rapid Micro Biosystems Inc
Glance View
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. The company is headquartered in Lowell, Massachusetts and currently employs 220 full-time employees. The company went IPO on 2021-07-15. The firm provides automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct platform automates and modernizes the manual microbial quality control (MQC), testing workflows used in pharmaceutical manufacturing operations across the globe. The Growth Direct platform helps on the manufacturing floor, unlocking the power of in-line/at-the-line MQC automation to deliver results with data regulations, and decision making that its customers rely on to ensure the supply of healthcare products. The Company’s Growth Direct platform is the automated MQC solution. The firm offers two consumables plates to capture test samples for analysis on the Growth Direct, which includes an Environmental Monitoring (EM), consumable and a Water/Bioburden (W/BB) consumable.
